Industry

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969) announced today the acceptance of the biologics license application (BLA) for tafasitamab in combination with lenalidomide for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant (ASCT) by the Department of Health, the Hong Kong Special Administrative Region, China. … [Read more…]

Metformin reduced emergency room visits, hospitalization, and death from COVID-19 by more than half if started within 4 days of symptoms SAN FRANCISCO–(BUSINESS WIRE)–The widely available diabetes drug metformin reduced serious COVID outcomes by more than half if started within 4 days of symptoms, in a large, double-blind, randomized, controlled trial conducted by the University … [Read more…]

PARADISE VALLEY, Ariz.–(BUSINESS WIRE)–Vista Living Senior Care, Inc. is proud to announce the opening its fourth assisted living home in the Phoenix area and the first in Paradise Valley. The other three homes are in the Arcadia neighborhood on the other side of Camelback Mountain. The new home offers a similarly welcoming and intimate experience … [Read more…]

NEW YORK–(BUSINESS WIRE)–MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that members of its management team will participate in person at the following conferences in September 2022: Morgan Stanley 20th Annual Global … [Read more…]

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:25 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for … [Read more…]

– Clinical data update from a first-in-human phase 1 study of ALPN-303 in healthy adults and plans for multiple patient-based studies beginning in 2023 – – First look at data from NEON-2 study of davoceticept in combination with pembrolizumab in advanced malignancies – – Disease experts to discuss the current treatment landscape and unmet medical … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–$SPRB #Tildacerfont—Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Samir Gharib, President and Chief Financial Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022 at 5:00 … [Read more…]

SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 at 11:55am PT / … [Read more…]

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022 at 1:30 p.m. Eastern Time in New York, NY. About Personalis Personalis, Inc. is a leader in advanced cancer … [Read more…]

12 Runners Living With Parkinson’s Disease Raising Awareness, Funds And Inspiring Others To Exercise CHICAGO–(BUSINESS WIRE)–#Blueridgerelay–Twelve dedicated runners, all living with Parkinson’s Disease (PD), will take on one of the most grueling relay road races in the US –– the 208-mile Blue Ridge Relay (BRR) on September 9-10. The Team Synapse runners, despite the many … [Read more…]